Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01156844 · ClinicalTrials.gov registry record · Phase 2
Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol
A Phase 2 study, sponsored by Novartis Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 191
- Enrollment target
NCT01156844 is a Phase 2 study that has completed, run by Novartis Pharmaceuticals. The registered enrollment target is 191 participants.
The verdict
NCT01156844, a Phase 2 study, has completed, sponsored by Novartis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 191 participants
- Enrollment target
Study Summary
This study assessed the bronchodilator efficacy of three different regimens of indacaterol in patients with asthma
Interventions
- DRUG Indacaterol
- DRUG Placebo to Indacaterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2010-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01156844
The ClinicalTrials.gov registry entry for NCT01156844 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 191 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Pharmaceuticals, which has 1,375 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indacaterol is the first listed.
NCT01156844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01156844 about?
NCT01156844 is a clinical study titled "Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol". This study assessed the bronchodilator efficacy of three different regimens of indacaterol in patients with asthma
What is the current status of trial NCT01156844?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 191 participants. The study started on 2010-03.
What interventions are being tested in trial NCT01156844?
The interventions under investigation include: Indacaterol (DRUG), Placebo to Indacaterol (DRUG).
Who is sponsoring clinical trial NCT01156844?
This trial is sponsored by Novartis Pharmaceuticals, which has 1,375 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.